Palladam poultry units seek upgrade of facilities at lab in Panickampatti
Poultry units in and around Palladam are in anticipation of upgrade of facilities at Poultry Disease Diagnostic Laboratory (PDDL) of the Animal Husbandry Department at Panickampatti near Palladam, established about six years ago to carry out testing of feed and water samples.
Out of ₹6.92 crore sanctioned for the PDDL, ₹4.24 crore was for the Poultry Disease Diagnosis Laboratory and ₹2.56 crore for establishing a laboratory for poultry feed testing, it is learnt.
The PDDL was sanctioned with BSL (Bio-safety level) II and GLP (Good Laboratory Practice) system under the National Agricultural Development Programme. It was established with the intent of carrying out diagnosis of poultry diseases through conduct of post-mortem, testing of droppings, blood samples and other specimens for major diseases, including viral diseases such as New Castle Disease, Infectious Bursal Disease, Infectious Bronchitis, Avian Leucosis Complex, and common bacterial diseases like Salmonella, E.Coli, and parasitic infestations..
The collective request of the hundreds of poultry units for upgrade of the PDDL in Palladam was made known to Minister for Information and Publicity M.P. Saminathan, District Collector T. Christuraj and senior officials of the Animal Husbandry Department when they carried out an inspection of the facilities at the PDDL on Thursday.
The poultry units, in particular, laid emphasis on establishment of incinerator to dispose of dead chicken, and adequacy of manpower and machinery at the PDDL.
The PDDLs carry out sero monitoring and surveillance for poultry diseases, covering both commercial and back yard poultry farms. Strict vigil over mortality and transport of poultry in view of preparedness for avian influenza is one of the major responsibilities of these laboratories, sources in Tamil Nadu Veterinary and Animal Sciences University said.
At present, the poultry units continue to depend on the PDDL at Namakkal for these tests. Once the PDDL at Palladam is upgraded with the required manpower and machinery, it will be equipped to test serum samples as preliminary screening for antibodies against avian influenza and forward the positive samples to referral laboratories for further confirmation.
As per the 2019th census of the Animal Husbandry Department in Tiruppur region, poultry strength in the farm of backyard poultry was 10,97,579 and that of farm poultry 149,84,700. Tiruppur district is in the forefront in rearing of broiler birds under contract farming mainly in Palladam and Gudimangalam blocks, and Palladam has come to be known as a poultry hub with over 4,000 hatcheries and more than 50 broiler farms.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
20 hours ago
- Time of India
Can weight loss drugs like ozempic affect male genitalia ? A fact-check of the bizarre viral claim
A bizarre theory has taken over social media and Reddit forums in recent weeks: the claim that Ozempic—the diabetes and weight loss drug—can increase penis size. What began as anecdotal posts on Reddit has now snowballed into viral speculation, with some users attributing significant 'growth' in their genitals to the medication. But is there any truth to this? Let's unpack the incident, the science, and what medical experts have to say. The Reddit buzz: Where the theory began The conversation appears to have started on Reddit, where several male users taking Ozempic or similar GLP-1 drugs shared personal experiences. One user wrote, 'I recently measured myself down there and noticed I gained about one inch. Now I think people will say it was because of the fat loss. However, at the time I measured myself before (4 years ago), I was thinner. I also pressed during measurement before, and also this time. Has anyone else noticed this change in themselves?' Another Redditor added, 'Yes. I gained 1.5 inches in length. No joke. Like you I obviously know how long I was before I got very fat. Then after about seven months on Tirzepatide in my case I gained 1.5 inches in length. Definitely not all from weight loss.' What do the experts say? There is no peer-reviewed research confirming a direct link between Ozempic and an actual increase in penis size. However, experts have explained that any perceived changes are likely due to weight loss—specifically, the reduction of fat around the pubic region, which can make more of the penis visibly exposed. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 5 Books Warren Buffett Wants You to Read In 2025 Blinkist: Warren Buffett's Reading List This creates the illusion of growth, but does not reflect an actual increase in size. According to , the average penis size in the UK has increased from 5.17 inches to 5.63 inches between 2022 and 2024—nearly a 10% rise. In Venezuela, a far more extreme jump was reported: from 1.42 inches to 6.67 inches in the same period. Dr. Richard Viney, consultant urological surgeon at Queen Elizabeth Hospital in Birmingham, commented on the findings in an interview with , saying: 'Men's penises shorten as they get older (due to) increasing body fat and increasing prostate size drawing the penis back into the body. It is theoretically possible that new drugs like Ozempic and Wegovy, which are used to treat diabetes and obesity, respectively and can cause people to lose weight, could also be a factor. As men lose weight, their penises appear larger.' Meanwhile, a broader trend has also caught researchers' attention. A 2023 study in the World Journal of Men's Health found that average penis size globally had increased by 24% over the past 30 years. Yet, scientists remain unsure about what exactly is driving this change. Dr. Michael Eisenberg, who authored the study, told Stanford Medicine's Scope blog: 'Any overall change in development is concerning, because our reproductive system is one of the most important pieces of human biology. If we're seeing this fast of a change, it means that something powerful is happening to our bodies.' Can Ozempic increase penis size? Based on current evidence, the short answer is no, Ozempic does not directly cause an increase in penis size. What some men are observing is a visual difference due to weight loss, particularly around the pubic area, which can make the penis appear longer. This is a matter of perception, not actual growth in tissue or length. There is no clinical data proving that semaglutide (Ozempic's active ingredient) has any physiological effect on male genitalia. The claims floating online are largely anecdotal and should be treated as such until further scientific research is conducted. One step to a healthier you—join Times Health+ Yoga and feel the change
The Hindu
a day ago
- The Hindu
Palladam poultry units seek upgrade of facilities at lab in Panickampatti
Poultry units in and around Palladam are in anticipation of upgrade of facilities at Poultry Disease Diagnostic Laboratory (PDDL) of the Animal Husbandry Department at Panickampatti near Palladam, established about six years ago to carry out testing of feed and water samples. Out of ₹6.92 crore sanctioned for the PDDL, ₹4.24 crore was for the Poultry Disease Diagnosis Laboratory and ₹2.56 crore for establishing a laboratory for poultry feed testing, it is learnt. The PDDL was sanctioned with BSL (Bio-safety level) II and GLP (Good Laboratory Practice) system under the National Agricultural Development Programme. It was established with the intent of carrying out diagnosis of poultry diseases through conduct of post-mortem, testing of droppings, blood samples and other specimens for major diseases, including viral diseases such as New Castle Disease, Infectious Bursal Disease, Infectious Bronchitis, Avian Leucosis Complex, and common bacterial diseases like Salmonella, and parasitic infestations.. The collective request of the hundreds of poultry units for upgrade of the PDDL in Palladam was made known to Minister for Information and Publicity M.P. Saminathan, District Collector T. Christuraj and senior officials of the Animal Husbandry Department when they carried out an inspection of the facilities at the PDDL on Thursday. The poultry units, in particular, laid emphasis on establishment of incinerator to dispose of dead chicken, and adequacy of manpower and machinery at the PDDL. The PDDLs carry out sero monitoring and surveillance for poultry diseases, covering both commercial and back yard poultry farms. Strict vigil over mortality and transport of poultry in view of preparedness for avian influenza is one of the major responsibilities of these laboratories, sources in Tamil Nadu Veterinary and Animal Sciences University said. At present, the poultry units continue to depend on the PDDL at Namakkal for these tests. Once the PDDL at Palladam is upgraded with the required manpower and machinery, it will be equipped to test serum samples as preliminary screening for antibodies against avian influenza and forward the positive samples to referral laboratories for further confirmation. As per the 2019th census of the Animal Husbandry Department in Tiruppur region, poultry strength in the farm of backyard poultry was 10,97,579 and that of farm poultry 149,84,700. Tiruppur district is in the forefront in rearing of broiler birds under contract farming mainly in Palladam and Gudimangalam blocks, and Palladam has come to be known as a poultry hub with over 4,000 hatcheries and more than 50 broiler farms.
Time of India
2 days ago
- Time of India
McDonald's downgraded amid Ozempic craze - investors worry fast food losing charm, stock under pressure
McDonald's stock was downgraded by analysts following concerns that weight-loss drugs like Ozempic could curb fast-food demand. Analysts suggested that these drugs, which reduce appetite, might lead to a significant drop in customer visits, potentially costing the company millions in revenue. Tired of too many ads? Remove Ads Equity Firm Downgrades McDonald's Stock How GLP-1 Medications Could Disrupt Fast Food Demand McDonald's Potential Revenue Losses and Customer Visit Declines Tired of too many ads? Remove Ads Inflation Adds Fuel to McDonald's Challenges Not Many Americans Are Using These Drugs Yet FAQs McDonald's faced a rough day on Wall Street Tuesday as shares dipped 1.7%, shaken by growing concerns that popular weight-loss drugs like Ozempic could seriously cut into the fast food giant's business, as per a analysis firm Redburn Atlantic lowered its rating on McDonald's stock by two notches from 'buy' to 'sell,' warning that the widespread use of GLP-1 drugs, which curb appetite and help regulate blood sugar, may change how Americans eat, potentially leading to a drop in millions of visits to McDonald's every year, as per CBS Redburn analysis described GLP-1 drugs like Ozempic and Wegovy as "demand disruptors" for restaurants like McDonald's , as they reduce consumers' appetites and limit the number of calories they consume each day, reported CBS News. Analysts wrote that, "These features of the drugs could have serious implications for the restaurant industry," according to the READ: YouTube loosens content rules, says freedom of expression can outweigh harm—controversial videos may return Analysts Chris Luyckx and Edward Lewis estimated that McDonald's could lose up to 28 million customer visits annually, resulting in nearly $482 million in lost revenue, roughly 0.9% of the company's sales, according to the concern is that GLP-1 drugs may shift eating habits, especially among lower-income consumers, who are the fast food chain's target market and who might cut back on dining out and keep those new habits long-term, as per CBS analysts pointed out that the "Behaviour changes extend beyond the individual user — reshaping group dining, influencing household routines and softening habitual demand. A 1% drag today could easily build to 10% or more over time, particularly for brands skewed toward lower income consumers or group occasions," quoted CBS to the pressure, rising prices and inflation might make it even harder for McDonald's to maintain its appeal to its customers, as per the report. The analysts highlighted that, "Consumers are showing clear signs of pricing fatigue after years of aggressive menu inflation," adding, "Although the gap between eating out and at home has narrowed, it remains historically wide, reinforcing value concerns," quoted CBS the adoption of the GLP-1 drugs has yet to reach a wider audience, as only 12% of Americans have tried the drugs, and currently just 6% of the adult population uses them, as per the the managing director and restaurant and food distributors analyst at BTIG global financial services, Peter Saleh said, "I don't think there would be a meaningful GLP-1 impact on McDonald's right now, but that's not to say that in three or four years that won't be the case," adding, "I just don't think we are there yet," quoted CBS medications that help regulate blood sugar and suppress appetite, often used for weight loss, as per to $482 million a year, according to some analysts.
